drugset / Trial / NCT01456247
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
RandomizedParallel-groupSingle-blindPrevention
Summary
The purpose of this study is to evaluate the safety of TAK-438, once daily (QD), during long-term concomitant low-dose aspirin therapy in patients with a history of gastric or duodenal ulcer who require long-term therapy of low-dose aspirin.
Timeline
- Start
- 2012-03
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lansoprazole | Other / unclassified | 15 mg | Oral |
| Subject | Vonoprazan | Other / unclassified | 10 mg | Oral |
| Subject | Vonoprazan | Other / unclassified | 20 mg | Oral |